Osteocytes and Paget's Disease of Bone.
Osteoclast
Osteocyte
Paget’s bone disease
RANKL
Senescence
Journal
Current osteoporosis reports
ISSN: 1544-2241
Titre abrégé: Curr Osteoporos Rep
Pays: United States
ID NLM: 101176492
Informations de publication
Date de publication:
08 Mar 2024
08 Mar 2024
Historique:
accepted:
09
02
2024
medline:
8
3
2024
pubmed:
8
3
2024
entrez:
8
3
2024
Statut:
aheadofprint
Résumé
To describe the contributions of osteocytes to the lesions in Paget's disease, which are characterized by locally overactive bone resorption and formation. Osteocytes, the most abundant cells in bone, are altered in Paget's disease lesions, displaying increased size, decreased canalicular length, incomplete differentiation, and less sclerostin expression compared to controls in both patients and mouse models. Pagetic lesions show increased senescent osteocytes that express RANK ligand, which drives osteoclastic bone resorption. Abnormal osteoclasts in Paget's disease secrete abundant IGF1, which enhances osteocyte senescence, contributing to lesion formation. Recent data suggest that osteocytes contribute to lesion formation in Paget's disease by responding to high local IGF1 released from abnormal osteoclasts. Here we describe the characteristics of osteocytes in Paget's disease and their role in bone lesion formation based on recent results with mouse models and supported by patient data.
Identifiants
pubmed: 38457001
doi: 10.1007/s11914-024-00863-5
pii: 10.1007/s11914-024-00863-5
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : NIH R01-AR057308
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01-AR090116-01
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016059
Pays : United States
Informations de copyright
© 2024. The Author(s).